探讨宫腔镜下输卵管插管通液术治疗不孕症的临床疗效。

将2006年12月至2007年1月在本院接受治疗的90例输卵管性不孕患者(心电图、肝功能检查均正常，排除妇科炎症及其他宫腔镜下输卵管插管通液术治疗禁忌证)，将其随机分为治疗组(n＝45，采用宫腔镜下输卵管插管通液术治疗)和对照组(n＝45，采用常规输卵管通液术治疗)(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准，得到该委员会批准，分组征得受试对象本人的知情同意，并与之签署临床研究知情同意书)。观察两组疗效和经治疗后半年内妊娠率。

治疗组输卵管通畅率为71.11%(32/45)，对照组为28.89%(13/45)，两组比较，差异有显著意义(P<0.01)；治疗组经治疗后，半年内妊娠率为62.22%(28/45)，对照组为24.44%(11/45)，两组比较，差异有显著意义(P<0.01)。

宫腔镜下输卵管插管通液术治疗输卵管性不孕疗效远优于常规输卵管通液术。

To study clinical effects of tubal catheterization and hydrotubation using hysteroscopy in the treatment of infertility.

From December 2006 to January 2007, 90 cases of infertile women of oviduct obstruction were divided into treatment group (n=45) and control group (n=45) randomly. Informed consent was obtained from all participates. The patients in control group accepted tubal hydrotubation, and treatment group accepted tubal catheterization and hydrotubation using hysteroscopy. The rates of tubal repatency and pregnancy were observed.

The rates of tubal repatency were 71.11%(32/45) in treatment group, and 28.89%(13/45) in control group, which had significant difference between two groups (P<0.01). In half a year after the treatment, the rates of pregnancy were 62.22%(28/45) and 24.44%(11/45) in treatment group and control group, respectively, which also had significant difference between two groups (P<0.01).

The clinical effect of tubal catheterization and hydrotubation using hysteroscopy in the treatment of oviduct infertility is superior to that of tubal hydrotubation greatly.